Google Received 12,000 Requests to be 'Forgotten' on First Day, Report Says and 10 More

Not displaying correctly? View this newsletter online.

Google Received 12,000 Requests to be 'Forgotten' on First Day, Report Says Google has already received 12,000 requests from EU citizens who wish to be "forgotten" from search results, according to a new report. 20 Things Other Than Napster Released in 1999 June 1 marks the 15th anniversary of Napster. Your head will explode when you remember what else released in 1999. 6 Can't-Miss Apps: Sunrise Calendar for Android and More This week's list includes an app to keep track of all your bookmarks, The Guardian's redesigned app and Sunrise, a great iPhone calendar coming to Android. 3 High-Tech Eyeglasses That Do Things Google Glass Can't Google Glass isn't the only wearable tech in town. Here a a few devices that give it a run for its money. Turkish Police Detain CNN Reporter On-Air on Gezi Anniversary [VIDEO] Turkish police detained journalist Ivan Watson while he was reporting live on-air Saturday, on the one-year anniversary of last summer's Gezi Park protests. Quick, Save Your Work: Justin.tv to Delete All Video Archives Justin.tv announced plans to delete all video-streaming archives, and end future video-recording options. Prisoner Swap Frees U.S. Soldier Held by Taliban for 5 Years The White House has agreed to release five Taliban prisoners in exchange for U.S. Army Sgt. Bowe Bergdahl, who had been held in Afghanistan for five years. In Photos: Moscow Gay-Pride Rallies Have Been Reduced to This A handful of demonstrators took to the streets in two small gay-pride rallies in Moscow on Saturday, but turnout was poor, even compared to last year. 17 DIY Bathroom Hacks to Make Your Experience Less Crappy The bathroom is the worst room in the house, but these tips, tricks and hacks will help make it a little more tolerable. 3D-Printed Accessories That Make Google Glass Even Dorkier Google Glass has been blasted as nerdy, dorky, and just plain ugly. Now a line of 3D-printed accessories makes that even truer. 25 TV Theme Songs Every '90s Kid Will Remember A nostalgic look at TV theme songs from your childhood. Read more at Mashable.com ▶ You received this email because you are registered on mashable.com. We respect your privacy. If you believe this has been sent to you in error, please safely unsubscribe. Mashable, Inc. is a Delaware Corporation. P.O. Box 64 New York, NY, 10159-0064

Velocity Alert: Apple WWDC 2014: What to Expect

Not displaying correctly? View this newsletter online.

THIS STORY IS ABOUT TO GO VIRAL

Apple WWDC 2014: What to Expect If you use an iPhone, iPad or Mac, Monday is the day everything changes. Apple will shake up its software platforms with iOS 8 and OS X 10.10. How does Mashable know what's going viral? Mashable built a system called Velocity, which scours the social web, collecting lots and lots of data around how people are engaging with published articles. It then pulls all of that data back to Mashable, dumps it into our own predictive engine, and predicts which articles are about to go viral. Read more at Mashable.com ▶ Mashable, Inc. is a Delaware Corporation. P.O. Box 64 New York, NY, 10159-0064

If you believe this has been sent to you in error, please safely unsubscribe.

ScienceDaily: Health & Medicine News

---

• Immune therapy for advanced bladder cancer yields promising results
• Ibrutinib as second-line therapy for chronic lymphocytic leukemia supported by study
• Preventing early menopause in breast cancer patients with new drug treatment
• Internalized stigma linked with poor self esteem, pain self-efficacy

Immune therapy for advanced bladder cancer yields promising results Posted: 31 May 2014 06:07 AM PDT A multi-center phase I study using an investigational drug for advanced bladder cancer patients who did not respond to other treatments has shown promising results in patients with certain tumor types, researchers report. The trial included 68 people with previously treated advanced bladder cancer, including 30 patients identified as PD-L1 positive. PD-L1 is a protein expressed by many tumor types that can render the cancer invulnerable to immune attack.

Ibrutinib as second-line therapy for chronic lymphocytic leukemia supported by study Posted: 31 May 2014 06:07 AM PDT In a head-to-head comparison of two Food and Drug Administration-approved drugs for the treatment of relapsed chronic lymphocytic leukemia, ibrutinib significantly outperformed ofatumumab as a second-line therapy, according to a multicenter interim study. Ibrutinib is the first drug designed to target Bruton's tyrosine kinase, a protein essential for CLL-cell survival and proliferation.

Preventing early menopause in breast cancer patients with new drug treatment Posted: 30 May 2014 11:24 AM PDT Among young breast cancer patients, one of the most distressing side effects of chemotherapy is early menopause. But a major study finds the risk of early menopause can be significantly reduced by adding the drug goserelin to the chemotherapy regimen.

Internalized stigma linked with poor self esteem, pain self-efficacy Posted: 30 May 2014 06:22 AM PDT After controlling for depression, internalized stigma is negatively associated with lower levels of self-esteem and personal control of pain, a study shows. Internalized stigma refers to the internalization or absorption of negative attitudes. It also is linked with a greater tendency to catastrophize about pain and with a reduced sense of personal control over pain.

You are subscribed to email updates from Health & Medicine News -- ScienceDaily To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610

ScienceDaily: Top News

---

Immune therapy for advanced bladder cancer yields promising results Posted: 31 May 2014 06:07 AM PDT A multi-center phase I study using an investigational drug for advanced bladder cancer patients who did not respond to other treatments has shown promising results in patients with certain tumor types, researchers report. The trial included 68 people with previously treated advanced bladder cancer, including 30 patients identified as PD-L1 positive. PD-L1 is a protein expressed by many tumor types that can render the cancer invulnerable to immune attack.

Preventing early menopause in breast cancer patients with new drug treatment Posted: 30 May 2014 11:24 AM PDT Among young breast cancer patients, one of the most distressing side effects of chemotherapy is early menopause. But a major study finds the risk of early menopause can be significantly reduced by adding the drug goserelin to the chemotherapy regimen.

You are subscribed to email updates from All Top News -- ScienceDaily To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610